Form 4: Credo Technology CFO Sells Shares Under 10b5-1 Plan

Credo Technology Group Holding Ltd reports that Chief Financial Officer Daniel W. Fleming sold a total of 27,794 ordinary shares across multiple transactions between June 10 and June 11, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Daniel W. Fleming, Chief Financial Officer of Credo Technology Group Holding Ltd, engaged in a series of stock sales between June 10 and June 11, 2026.
• A total of 27,794 ordinary shares were sold.
• The sales were conducted under a Rule 10b5-1 trading plan, adopted on January 12, 2026, which is designed to comply with affirmative defense conditions.
• On June 10, 2026, 11,805 shares were acquired by the issuer to satisfy tax withholding obligations related to the vesting and settlement of RSUs, at a price of $237.68 per share.
• Subsequent sales on June 11, 2026, involved a total of 15,989 shares, with weighted average sale prices ranging from $242.50 to $252.37.
• Following these transactions, Fleming beneficially owns 501,873 ordinary shares directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to the sale of a notable number of shares by the CFO, despite the transactions being executed under a pre-arranged 10b5-1 plan.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-impactful sales.
• The acquisition of shares on June 10 was to cover tax withholding obligations, a standard procedure for RSU settlements.

Negatives

• A significant number of shares (15,989) were sold by a key executive, the CFO, which could be perceived negatively by the market.
• The sales occurred over a short period, suggesting a deliberate divestment of a portion of the executive's holdings.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a pre-arranged plan.
• The weighted average sale prices indicate a downward trend in the sale prices throughout June 11, 2026, though this is typical for multiple trades over a day.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future financial performance.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2026.
• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4 filings, particularly those involving sales by senior executives, are closely watched by investors. While sales under a Rule 10b5-1 plan are generally viewed as less indicative of negative sentiment than unsolicited sales, significant volumes can still influence market perception. Credo Technology operates in the competitive semiconductor industry, where executive confidence and capital allocation are key indicators.

Stakeholder Impact

• Shareholders may interpret the CFO's stock sales as a signal, potentially leading to short-term price pressure.
• Employees holding RSUs may note the tax withholding process as a standard procedure for equity compensation.
• Creditors and suppliers are unlikely to be directly impacted by this insider stock transaction.

Next Steps

• Continued monitoring of insider transactions for any further sales or purchases by Credo Technology executives.
• Analysis of future company performance reports to assess the underlying reasons for any executive stock sales.

Key Dates

Recommendation

The filing details routine stock sales by the CFO under a pre-established 10b5-1 plan. While insider selling can be a negative signal, the structured nature of these sales mitigates immediate concern. Without further context on the company's performance or the executive's personal financial situation, a 'hold' recommendation is prudent, pending additional information.

Keywords

Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Credo Technology, CRDO, Daniel W. Fleming, Chief Financial Officer, RSU Vesting, Tax Withholding